AKBA
Akebia Therapeut (AKBA)
NASDAQ
$0.58+$0.003 (+0.58%)
Price as of Nov 12, 2026 8:17 AM EST
  • $159.3M
    Market Cap
  • -68.99%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 62
Valuation
AKBA
vs History
vs S&P 500
Profitability
1
Growth
1
Low Earnings Volatility
1

Momentum Score

Score: 21
Valuation
AKBA
vs History
vs S&P 500
3-Month Momentum
-11.14%
12-Month Momentum
-57.46%
3-Month Risk Adjusted Momentum
-46.50%
12-Month Risk Adjusted Momentum
-86.00%

True Yield

N/A
Valuation
AKBA
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
-0.18%

Financial Health Score

Score: 85
Valuation
AKBA
vs History
vs S&P 500
Ohlson's O-Score
7